03.20.26 -- Pursuing Quality While Maintaining Process Control With Richard Moroney, Ph.D.

Multiple AI use cases with significant impact have been identified, and they are expected to drive innovations in clinical trials, precision medicine, and commercial operations.

Many advanced therapies stall due to weak preclinical planning and poor partner vetting. Learn how stronger upfront strategy can prevent costly delays and keep programs on track.

Clear payment policies rely on distinguishing reimbursement from stipends. Explore the ethical principles that protect participant respect and reduce financial barriers to trial involvement.

Antibody-drug conjugates (ADCs) combine antibody targeting with potent cytotoxic payloads to treat resistant cancers, but their complexity requires phase-appropriate analytical strategies.

Uncover the benefits of this CGMP-ready, stable AAV packaging cell line with proven expertise to reduce costs, streamline manufacturing, and make life-changing gene therapies more accessible to patients in need.

Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.